POCTRN Solicitation 2022 - POCTRN

null POCTRN Solicitation 2022

POCTRN Solicitation 2022

Do you have a promising point-of-care medical technology in need of further development? 

The NIH’s Point-of-Care Technology Research Network (POCTRN) drives the development of point-of-care technologies through collaborative efforts that merge scientific and technological capabilities with clinical need.

We are pleased to announce new funding opportunities from our centers:

Atlanta Center for Microsystems Engineered Point-of-Care Technologies

Microfluidics/Lab-on-a-Chip/
Microchip-Based Point-of-Care Technologies 
 

Learn More or Apply » 
 

Center for Advancing Point of 
Care Technologies in Heart, 
Lung, Blood and Sleep Disorders

Funding Opportunity: 
Center for Advancing Point of Care Technologies in Heart, Lung, 
Blood and Sleep Disorders

Learn More or Apply » 
 

Center for Innovation in Point 
of Care Technologies for 
HIV/AIDS at Northwestern

Point-of-Care Technologies 
for HIV/AIDS in Low- and   
Middle-Income Countries 
 

Learn More or Apply » 
 

The Johns Hopkins University Center for Point-of-Care Technologies Research for 
Sexually Transmitted Diseases

Improvements to Rapid Simple 
Point-of-Care Tests for Sexually Transmitted Diseases

Learn More or Apply » 
 

The application period for this opportunity has passed.

RADx: Rapid Acceleration of Diagnostics

In response to the COVID-19 pandemic, the Rapid Acceleration of Diagnostics (RADxsm) initiative was formed to accelerate the development, validation, and commercialization of innovative point-of-care and home-based tests, as well as improvements to clinical laboratory tests, that can directly detect SARS-CoV-2, the virus that causes COVID-19.

ABOUT RADx

In the News 

Two New Over-the-Counter At-Home COVID-19 Tests Brought to U.S. Market Quickly by Biden-Harris Administration

New HHS actions add to Biden administration efforts to increase access to easy-to-use over-the-counter COVID-19 tests

NIH RADx initiative expands COVID-19 testing innovation for additional types of rapid tests

The need for new test verification and regulatory support for innovative diagnostics

NIH-funded screening study builds case for frequent COVID-19 antigen testing

RADx partnerships speed new COVID testing

One Year of RADx Tech Success

Publication reveals essential ingredients of the groundbreaking NIH RADx national diagnostics effort 

Innovative COVID-19 Testing RADx Tech Reports Unveiled in Special Issue of IEEE Open Journal of Engineering in Medicine and Biology

Luminostics Announces FDA Authorization and Production Scale-Up of US-Manufactured Smartphone-Based COVID-19 Rapid Test

RADx Expects COVID-19 Portfolio to Accelerate an Era of At-Home Infectious Disease Testing (Login Required)

VIC Foundry, Inc. Receives NIH RADx Funding for Development of an At-home Molecular Diagnostic Test for COVID-19

Ceres Nanosciences Opens Advanced Particle Manufacturing Plant in Northern Virginia to Expand Nanotrap® Particle Manufacturing Capacity for COVID-19 Testing

COVID-19 Testing: Three Breakthrough Solutions in the RADx Initiative

NIH Director: Collaboration Amid Chaos, and Biden’s First 100 Days - How Francis Collins sees the COVID response changing with the new administration

The National Strategy From the COVID-19 Response and Pandemic Preparedness

Winners of HHS Design-a-thon to Develop Innovative Digital Health Tools for COVID-19 At-Anywhere Diagnostic Tests Announced

The Need for More and Better Testing for COVID-19